IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i10p6182-d819227.html
   My bibliography  Save this article

Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer

Author

Listed:
  • Eri Haneda

    (Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Ann Sato

    (Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Nobuyasu Suganuma

    (Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama 241-8515, Japan
    Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Yoshiko Sebata

    (Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama 241-8515, Japan
    Department of Nursing, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Saki Okamoto

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Soji Toda

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Kaori Kohagura

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Yuka Matsubara

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Yuko Sugawara

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Takashi Yamanaka

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Toshinari Yamashita

    (Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Satoru Shimizu

    (Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama 241-8515, Japan)

  • Hiroto Narimatsu

    (Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama 241-8515, Japan
    Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama 241-8515, Japan
    Graduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki 210-0821, Japan)

Abstract

Clinical screening using the National Comprehensive Cancer Network (NCCN) testing criteria may fail to identify all patients with hereditary breast and ovarian cancers. Thus, this study aimed to evaluate the strategy of expanding target patients for genetic testing among Japanese patients. We reviewed the medical records of 91 breast cancer patients who underwent genetic testing. Among 91 patients, eight were diagnosed with pathogenic or likely pathogenic variants: BRCA1 (n = 4) and BRCA2 (n = 4). Among 50 patients meeting the testing criteria of the guidelines, 6 (12%) were diagnosed with pathogenic or likely pathogenic variants. The sensitivity and specificity of screening using the testing criteria were 75% and 47%, respectively. Expanding the NCCN criteria to include all women diagnosed with breast cancer aged ≤65 years achieved 88% sensitivity but 8% specificity. The expansion of the NCCN criteria could benefit Japanese patients; however, larger studies are necessary to change clinical practice.

Suggested Citation

  • Eri Haneda & Ann Sato & Nobuyasu Suganuma & Yoshiko Sebata & Saki Okamoto & Soji Toda & Kaori Kohagura & Yuka Matsubara & Yuko Sugawara & Takashi Yamanaka & Toshinari Yamashita & Satoru Shimizu & Hiro, 2022. "Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer," IJERPH, MDPI, vol. 19(10), pages 1-6, May.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:10:p:6182-:d:819227
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/10/6182/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/10/6182/
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    HBOC; NCCN; screening; genetic testing; BRCA1/2;
    All these keywords.

    JEL classification:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:10:p:6182-:d:819227. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.